nohealthproblemsnews.com
Home » Coronavirus Disease COVID-19 »
The causative agent of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in Wuhan, […] The emergence of a novel human coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in Wuhan, […] The onset of the coronavirus disease 2019 (COVID-19) brought about intensive research on the biological characteristics of the pathogen responsible, […] Despite high vaccination rates, analysis shows a definite positive impact, but patience is needed to see the real-world impacts in […] Extensive testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a primary mitigation measure in controlling […] In a pandemic, uncertainty is salient, especially concerning the effectiveness of treatments, policies, and outcomes. This is especially evident during […] When researchers analyzed the responses of the COVID-19 Symptom Survey in the United States, they found an increased risk of […] A recent theoretical paper, currently available on the medRxiv* preprint server, unveils a novel vaccination model that shows how a […] Researchers in the United States have suggested a new approach to treating infection with coronaviruses such as severe acute respiratory […] The emergence of the novel coronavirus disease (COVID-19) was first reported in Wuhan, China, in December 2019 and its rapid […]
Researchers evaluate antibodies that inhibit SARS-CoV-2 RBD variants with a novel assay
Researchers develop new rapid and highly sensitive SAR-CoV-2 RNA detection test
Neutralizing antibodies to SARS-CoV-2 in mice depend on Fc effector function
How effective has rapid COVID-19 vaccination been in Israel?
Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies
Failing to communicate COVID-19 vaccine uncertainties has negative consequences
COVID risk to households and teachers from in person schooling
A model of vaccine-derived herd immunity against COVID-19 in heterogeneous populations
GSK-3 inhibitors show promise in treating coronavirus infections
Does climate play a large role in SARS-CoV-2 transmission?
